{"id":"2594007GAALFMXP4YB89-2023-12-31-ESEF-PL-0","name":"BioMaxima Spółka Akcyjna","country":"PL","fiscal_year":2023,"period_start":"2023-01-01","period_end":"2023-12-31","currency":"PLN","values":{"REVENUE":46786000.0,"OPERATING_RESULT":728000.0,"PROFIT_BEFORE_TAX":187000.0,"TAX_EXPENSE":-399000.0,"PROFIT":586000.0,"PROFIT_PARENT":586000.0,"PROFIT_NCI":0.0,"ASSETS_NONCURRENT":38196000.0,"ASSETS_CURRENT":36225000.0,"ASSETS_TOTAL":74421000.0,"EQUITY_PARENT":52456000.0,"EQUITY_NCI":0.0,"EQUITY":52456000.0,"LIABILITIES_NONCUR":10988000.0,"LIABILITIES_CURRENT":10977000.0,"LIABILITIES_TOTAL":21965000.0,"EQUITY_AND_LIABS":74421000.0},"concepts":{"REVENUE":"ifrs-full:Revenue","OPERATING_RESULT":"ifrs-full:ProfitLossFromOperatingActivities","PROFIT_BEFORE_TAX":"ifrs-full:ProfitLossBeforeTax","TAX_EXPENSE":"ifrs-full:IncomeTaxExpenseContinuingOperations","PROFIT":"ifrs-full:ProfitLoss","PROFIT_PARENT":"ifrs-full:ProfitLossAttributableToOwnersOfParent","PROFIT_NCI":"ifrs-full:ProfitLossAttributableToNoncontrollingInterests","ASSETS_NONCURRENT":"ifrs-full:NoncurrentAssets","ASSETS_CURRENT":"ifrs-full:CurrentAssets","ASSETS_TOTAL":"ifrs-full:Assets","EQUITY_PARENT":"ifrs-full:EquityAttributableToOwnersOfParent","EQUITY_NCI":"ifrs-full:NoncontrollingInterests","EQUITY":"ifrs-full:Equity","LIABILITIES_NONCUR":"ifrs-full:NoncurrentLiabilities","LIABILITIES_CURRENT":"ifrs-full:CurrentLiabilities","LIABILITIES_TOTAL":"ifrs-full:Liabilities","EQUITY_AND_LIABS":"ifrs-full:EquityAndLiabilities"},"checks":{"bs_identity":true,"bs_equity_liabs":true,"bs_assets_split":true,"bs_liabs_split":true,"bs_equity_split":true,"is_tax_bridge":true,"is_profit_split":true},"all_checks_passed":true,"derived":{"operating_margin_pct":1.5560210319326295,"net_margin_pct":1.2525114350446716,"equity_ratio_pct":70.48548124857231,"roe_pct":1.1171267347872502,"revenue_eur":10781426.431616545},"source":"https://filings.xbrl.org"}